IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $111,192 | -7.1% | 2,506 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $119,637 | +22.8% | 2,506 | +1.2% | 0.00% | +50.0% |
Q1 2023 | $97,431 | +39.8% | 2,476 | +0.5% | 0.00% | 0.0% |
Q4 2022 | $69,707 | -5.8% | 2,464 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $74,000 | -11.9% | 2,464 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $84,000 | -23.6% | 2,464 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $110,000 | -46.6% | 2,464 | -44.7% | 0.00% | -25.0% |
Q4 2021 | $206,000 | +38.3% | 4,456 | +0.4% | 0.00% | 0.0% |
Q3 2021 | $149,000 | +14.6% | 4,440 | +0.2% | 0.00% | +33.3% |
Q2 2021 | $130,000 | +14.0% | 4,433 | +0.6% | 0.00% | 0.0% |
Q1 2021 | $114,000 | +15.2% | 4,405 | +1.0% | 0.00% | 0.0% |
Q4 2020 | $99,000 | +6.5% | 4,360 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $93,000 | -7.9% | 4,360 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $101,000 | +8.6% | 4,360 | 0.0% | 0.00% | -25.0% |
Q1 2020 | $93,000 | -8.8% | 4,360 | 0.0% | 0.00% | +33.3% |
Q4 2019 | $102,000 | +10.9% | 4,360 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $92,000 | +3.4% | 4,360 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $89,000 | – | 4,360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
RK Capital | 222,914 | $5,212,000 | 1.95% |
Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |